相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer
Jing-Jing Wang et al.
BIOMOLECULES (2021)
Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site
Xi Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Cell-programmed nutrient partitioning in the tumour microenvironment
Bradley Reinfeld et al.
NATURE (2021)
The metabolism of cancer cells during metastasis
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2021)
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties
Michael J. Soth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase
Sarah C. Zirnmerrnann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions
Xi Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models
M. Raymond V. Finlay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors
Xi Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D. Leone et al.
SCIENCE (2019)
Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity
Zhao Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis
William P. Katt et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Design and evaluation of novel glutaminase inhibitors
Lee A. McDermott et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Cancer metabolism pipeline breaks new ground
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Matt I. Gross et al.
MOLECULAR CANCER THERAPEUTICS (2014)
A Small Molecule for Controlled Generation of Reactive Oxygen Species (ROS)
Allimuthu T. Dharmaraja et al.
ORGANIC LETTERS (2014)
Active Glutaminase C Self-assembles into a Supratetrameric Oligomer That Can Be Disrupted by an Allosteric Inhibitor
Amanda Petrina Scota Ferreira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Oral Glutamine Reduces Radiation Morbidity in Breast Conservation Surgery
Isabel Rubio et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2013)
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES)
Mary M. Robinson et al.
BIOCHEMICAL JOURNAL (2007)
Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence
HT Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
分享论文
